Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan.
OBJECTIVE
To verify the current status of super-extended lymph node dissection for advanced gastric cancer according to a questionnaire survey.


METHODS
One-hundred and five institutions responded to the questionnaire. The survey included the following items: Number of experiences, whether performed prophylactically and/or therapeutically, whether preoperative chemotherapy was provided, number of preoperative chemotherapy rounds, and therapeutic options after chemotherapy.


RESULTS
Eighty-seven of the 105 institutions (83%) had performed D3 gastrectomy in the past or continued to perform D3 gastrectomy at present. However, D3 gastrectomy was rarely performed prophylactically in clinical practice. Seventy-eight institutions (74%) indicated that preoperative chemotherapy with curative intent was required for patients suspected of having para-aortic node (PAN) metastases. After chemotherapy, a D3 gastrectomy was scheduled for patients with a complete or partial response, stable disease, and progressive disease at 36 (46%), 28 (36%), and 13 (17%) of the institutions, respectively.


CONCLUSIONS
For patients with apparent PAN metastasis, a D3 gastrectomy is typically planned if a few courses of preoperative chemotherapy yield at least a stable disease condition.
Shinji Morita, Takeo Fukagawa, Hisataka Fujiwara, Hitoshi Katai, Department of Surgical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045, Japan.
Shinji
S
Morita
Shinji Morita, Takeo Fukagawa, Hisataka Fujiwara, Hitoshi Katai, Department of Surgical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045, Japan.
Takeo
T
Fukagawa
Shinji Morita, Takeo Fukagawa, Hisataka Fujiwara, Hitoshi Katai, Department of Surgical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045, Japan.
Hisataka
H
Fujiwara
Shinji Morita, Takeo Fukagawa, Hisataka Fujiwara, Hitoshi Katai, Department of Surgical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045, Japan.
Hitoshi
H
Katai
Advanced gastric cancer; Para-aortic nodal dissection; Preoperative chemotherapy; Questionnaire survey; Radical surgery
Cancer. 1991 Oct 1;68(7):1501-6
1893349
J Clin Oncol. 1992 Dec;10(12):1933-42
1453207
Br J Surg. 2014 May;101(6):653-60
24668391
Oncology. 1995 Jan-Feb;52(1):45-50
7800342
Eur J Surg Oncol. 2004 Aug;30(6):643-9
15256239
Br J Surg. 2009 Sep;96(9):1015-22
19644974
Gastric Cancer. 2003;6(3):159-67
14520529
World J Surg. 1987 Aug;11(4):418-25
3630186
Int Surg. 1991 Oct-Dec;76(4):222-5
1778720
Br J Surg. 1995 Mar;82(3):346-51
7796005
Hepatogastroenterology. 2000 May-Jun;47(33):893-6
10919056
Ann Surg Oncol. 2011 Aug;18(8):2265-72
21267792
Gastric Cancer. 2011 Oct;14(4):301-16
21894577
J Clin Oncol. 1996 Jun;14 (6):1818-28
8656250
J Clin Oncol. 2004 Jul 15;22(14):2774-80
15254045
N Engl J Med. 2008 Jul 31;359(5):453-62
18669424
J Natl Cancer Inst. 1993 Nov 17;85(22):1839-44
8230264
J Surg Oncol. 2010 Mar 15;101(4):305-14
20187070
Gastric Cancer. 2012 Sep;15 Suppl 1:S38-47
21667136
Ann Surg Oncol. 2008 Aug;15(8):2146-52
18543037
N Engl J Med. 2007 Nov 1;357(18):1810-20
17978289
Gastric Cancer. 2014;17(3):514-21
23999869
Ann Oncol. 2006 Sep;17(9):1404-11
16788003
Gastric Cancer. 2011 Jun;14(2):97-100
21573921
Hepatogastroenterology. 1999 Jul-Aug;46(28):2635-42
10522056
N Engl J Med. 2001 Sep 6;345(10):725-30
11547741
Br J Surg. 1984 Nov;71(11):863-6
6208963
Cancer. 2001 Mar 1;91(5):918-27
11251943
Ann Surg Oncol. 2001 Jul;8(6):519-24
11456051
N Engl J Med. 2006 Jul 6;355(1):11-20
16822992
Ann Surg Oncol. 2006 May;13(5):659-67
16538414